1. Home
  2. OCGN vs FLXS Comparison

OCGN vs FLXS Comparison

Compare OCGN & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • FLXS
  • Stock Information
  • Founded
  • OCGN 2013
  • FLXS 2001
  • Country
  • OCGN United States
  • FLXS United States
  • Employees
  • OCGN N/A
  • FLXS N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • FLXS Home Furnishings
  • Sector
  • OCGN Health Care
  • FLXS Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • FLXS Nasdaq
  • Market Cap
  • OCGN 229.2M
  • FLXS 254.4M
  • IPO Year
  • OCGN N/A
  • FLXS N/A
  • Fundamental
  • Price
  • OCGN $0.68
  • FLXS $46.29
  • Analyst Decision
  • OCGN Strong Buy
  • FLXS
  • Analyst Count
  • OCGN 3
  • FLXS 0
  • Target Price
  • OCGN $6.00
  • FLXS N/A
  • AVG Volume (30 Days)
  • OCGN 3.5M
  • FLXS 37.5K
  • Earning Date
  • OCGN 03-05-2025
  • FLXS 02-03-2025
  • Dividend Yield
  • OCGN N/A
  • FLXS 1.47%
  • EPS Growth
  • OCGN N/A
  • FLXS 23.31
  • EPS
  • OCGN N/A
  • FLXS 3.55
  • Revenue
  • OCGN $4,700,000.00
  • FLXS $430,531,000.00
  • Revenue This Year
  • OCGN N/A
  • FLXS $8.73
  • Revenue Next Year
  • OCGN N/A
  • FLXS $5.13
  • P/E Ratio
  • OCGN N/A
  • FLXS $13.03
  • Revenue Growth
  • OCGN N/A
  • FLXS 7.75
  • 52 Week Low
  • OCGN $0.64
  • FLXS $28.81
  • 52 Week High
  • OCGN $2.11
  • FLXS $65.87
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 40.75
  • FLXS 39.68
  • Support Level
  • OCGN $0.67
  • FLXS $49.24
  • Resistance Level
  • OCGN $0.76
  • FLXS $55.00
  • Average True Range (ATR)
  • OCGN 0.04
  • FLXS 3.68
  • MACD
  • OCGN 0.00
  • FLXS -0.61
  • Stochastic Oscillator
  • OCGN 28.57
  • FLXS 3.54

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

Share on Social Networks: